BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9238761)

  • 1. The effect of Losartan, an angiotensin II antagonist, on cardiac function, mass and morphology in rats after repeated hyperbaric exposures.
    Stuhr LE; Maehle BO
    Scand J Clin Lab Invest; 1997 May; 57(3):253-61. PubMed ID: 9238761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of SCH 42495, a neutral endopeptidase inhibitor, on cardiac function and mass in rats after repeated hyperbaric exposures.
    Stuhr LE
    Scand J Clin Lab Invest; 2000 Apr; 60(2):141-8. PubMed ID: 10817401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated normoxic hyperbaric exposures induce haemodynamic and myocardial changes in rats.
    Stuhr LE; Bergø GW; Skei S; Maehle BO; Tyssebotn I
    Eur J Appl Physiol Occup Physiol; 1993; 66(3):226-34. PubMed ID: 8477678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload.
    Ishiye M; Umemura K; Uematsu T; Nakashima M
    Biol Pharm Bull; 1995 May; 18(5):700-4. PubMed ID: 7492986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
    Mizuno K; Tani M; Hashimoto S; Niimura S; Sanada H; Watanabe H; Ohtsuki M; Fukuchi S
    Life Sci; 1992; 51(5):367-74. PubMed ID: 1385640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats.
    Gohlke P; Linz W; Schölkens BA; Wiemer G; Unger T
    Hypertension; 1996 Sep; 28(3):397-402. PubMed ID: 8794823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Kawano H; Cody RJ; Graf K; Goetze S; Kawano Y; Schnee J; Law RE; Hsueh WA
    Hypertension; 2000 Jan; 35(1 Pt 2):273-9. PubMed ID: 10642310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.
    Oddie CJ; Dilley RJ; Kanellakis P; Bobik A
    J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs.
    Susic D; Nuñez E; Frohlich ED; Prakash O
    Hypertension; 1996 Aug; 28(2):265-8. PubMed ID: 8707392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction.
    Dixon IM; Ju H; Jassal DS; Peterson DJ
    Mol Cell Biochem; 1996 Dec; 165(1):31-45. PubMed ID: 8974079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Yukimura T; Miura K; Iwao H
    Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
    Ruzicka M; Yuan B; Harmsen E; Leenen FH
    Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats.
    Ruzicka M; Leenen FH
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1551-6. PubMed ID: 8238566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
    Camargo MJ; von Lutterotti N; Campbell WG; Pecker MS; James GD; Timmermans PB; Laragh JH
    J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
    Cody RJ; Binkley PF; Haas GJ; Brown DM
    Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
    Golomb E; Abassi ZA; Cuda G; Stylianou M; Panchal VR; Trachewsky D; Keiser HR
    Am J Physiol; 1994 Oct; 267(4 Pt 2):H1496-506. PubMed ID: 7524366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.